Table of Contents 
Chemotherapy Research and Practice
Volume 2014, Article ID 856156, 4 pages
http://dx.doi.org/10.1155/2014/856156
Research Article

The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC Patients

Vanita Noronha,1 Amit Joshi,1 Anant Gokarn,1 Vibhor Sharma,1 Vijay Patil,2 Amit Janu,3 Nilendu Purandare,4 Anuradha Chougule,1 Nirmala Jambhekar,5 and Kumar Prabhash1

1Department of Medical Oncology, Tata Memorial Hospital, Dr. E. Borges Road, Parel, Mumbai, Maharashtra 400012, India
2Department of Medical Oncology, Malabar Cancer Center, Moozhikkara, Kannur, Kerala 670103, India
3Department of Radiodiagnosis, Tata Memorial Hospital, Dr. E. Borges Road, Parel, Mumbai, Maharashtra 400012, India
4Department of Nuclear Medicine, Tata Memorial Hospital, Dr. E. Borges Road, Parel, Mumbai, Maharashtra 400012, India
5Department of Pathology, Tata Memorial Hospital, Dr. E. Borges Road, Parel, Mumbai, Maharashtra 400012, India

Received 26 September 2014; Accepted 17 November 2014; Published 7 December 2014

Academic Editor: Vassilis Georgoulias

Copyright © 2014 Vanita Noronha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Vanita Noronha, Amit Joshi, Anant Gokarn, et al., “The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC Patients,” Chemotherapy Research and Practice, vol. 2014, Article ID 856156, 4 pages, 2014. https://doi.org/10.1155/2014/856156.